RELMADA THERAPEUTICS, INC. Employee Benefits and Share-based Compensation
RELMADA THERAPEUTICS, INC. (RLMD) reported Employee Benefits and Share-based Compensation of $12.56 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2024-11-07
- RELMADA THERAPEUTICS, INC. employee benefits and share-based compensation for the quarter ending 2020-03-31 was $1.50M.
| Period end | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 6 month | Employee Benefits and Share-based Compensation 9 month | Employee Benefits and Share-based Compensation 12 month |
|---|---|---|---|---|
| 2024-09-30 | $12.56K 10-Q · filed 2024-11-07 | |||
| 2023-09-30 | $61.20M 10-Q · filed 2023-11-08 | |||
| 2020-03-31 | $1.50M 10-Q · filed 2020-05-15 | |||
| 2017-12-31 | $71.00K 10-Q · filed 2018-02-12 | |||
| 2017-06-30 | $71.00K 10-Q · filed 2018-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |